Boutros (Peter) Sawaya, MD

Director, Nephrology Fellowship Training Program
Interim Director, CCTS-Clinical Services Core

Clinical interests

  • Chronic Kidney Disease
  • Dialysis
  • Hypertension
  • Kidney Stone Disease
  • Medical Education
  • Nephrology
  • Renal Diseases

Boutros (Peter) Sawaya, MD

Director, Nephrology Fellowship Training Program
Interim Director, CCTS-Clinical Services Core

Biography

My name is Boutros Peter Sawaya; I received my medical degree from Tishreen University, School of Medicine, Latakia, Syria. I completed fellowships at Henry Ford Hospital, Detroit and the University of Michigan Medical Center, Ann Arbor.

I am board certified by the American Board of Internal Medicine in Nephrology.

Faculty rank

Professor of Medicine

Education

Degree
Tishreen University, School of Medicine, Latakia, Syria

Residency
Good Samaritan Hospital, Cincinnati

Fellowship
Henry Ford Hospital, Detroit
University of Michigan Medical Center, Ann Arbor

Certifications or Special training
American Board of Internal Medicine
American Board of Internal Medicine, Nephrology

Nephrology, Bone & Mineral Metabolism

UK Good Samaritan Professional Arts Center
Suite 401
135 E. Maxwell St.
Lexington KY 40508-2640



Nephrology, Bone & Mineral Metabolism

UK HealthCare – Frankfort
Suite A
601 Chamberlin Ave.
Frankfort KY 40604


UK HealthCare accepts many forms of insurance. See list of insurers »

 
  1. El-Husseini A, Saxon D, Jennings S, Cornea V, Beck L, Sawaya BP. Idiopathic Membranous Nephropathy: Diagnostic and Therapeutic Challenges. Am J Nephrol. 2016;43(2):65-70.
    View in: PubMed
  2. Odden MC, McClure LA, Sawaya BP, White CL, Peralta CA, Field TS, Hart RG, Benavente OR, Pergola PE. Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial. Hypertension. 2016 Jan;67(1):63-9.
    View in: PubMed
  3. Areephanthu CJ, Bole R, Stratton T, Kelly TH, Starnes CP, Sawaya BP. Impact of Professional Student Mentored Research Fellowship on Medical Education and Academic Medicine Career Path. Clin Transl Sci. 2015 Oct;8(5):479-83.
    View in: PubMed
  4. El-Husseini A, Hannan S, Awad A, Jennings S, Cornea V, Sawaya BP. Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab. Am J Kidney Dis. 2015 Jan;65(1):127-30.
    View in: PubMed
  5. El-Husseini A, Sawaya BP. What is the role of bone biopsy in the management of adult dialysis patients? Semin Dial. 27(3):266-9.
    View in: PubMed
  6. Fraer M, Sekkarie MA, Rao R, Sawaya BP. Vascular access malfunction due to upper extremity embolization in dialysis patients. Clin Nephrol. 2008 Jan; 69(1):53-7. PMID: 18218317.
    View in: PubMed
  7. Fanti P, Asmis R, Stephenson TJ, Sawaya BP, Franke AA. Positive effect of dietary soy in ESRD patients with systemic inflammation--correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol Dial Transplant. 2006 Aug; 21(8):2239-46. PMID: 16766544.
    View in: PubMed
  8. Fraer M, Campbell A, Sawaya BP. Response to cyclosporine A in a patient with pure red cell aplasia due to antierythropoietin-alpha antibodies. Semin Dial. 2006 May-Jun; 19(3):251-4. PMID: 16689978.
    View in: PubMed
  9. Sawaya BP, Butros R, Naqvi S, Geng Z, Mawad H, Friedler R, Fanti P, Monier-Faugere MC, Malluche HH. Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. Kidney Int. 2003 Aug; 64(2):737-42. PMID: 12846773.
    View in: PubMed
  10. Trueba D, Sawaya BP, Mawad H, Malluche HH. Bone biopsy: indications, techniques, and complications. Semin Dial. 2003 Jul-Aug; 16(4):341-5. PMID: 12926408.
    View in: PubMed
  11. Sawaya BP, Monier-Faugere MC, Ratanapanichkich P, Butros R, Wedlund PJ, Fanti P. Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism. Clin Nephrol. 2002 Jan; 57(1):51-5. PMID: 11837801.
    View in: PubMed
  12. Mawad HW, Sawaya BP, Sarin R, Malluche HH. Calcific uremic arteriolopathy in association with low turnover uremic bone disease. Clin Nephrol. 1999 Sep; 52(3):160-6. PMID: 10499311.
    View in: PubMed
  13. Fanti P, Sawaya BP, Custer LJ, Franke AA. Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients. J Am Soc Nephrol. 1999 Apr; 10(4):864-71. PMID: 10203372.
    View in: PubMed
  14. Sawaya BP, Koszewski NJ, Qi Q, Langub MC, Monier-Faugere MC, Malluche HH. Secondary hyperparathyroidism and vitamin D receptor binding to vitamin D response elements in rats with incipient renal failure. J Am Soc Nephrol. 1997 Feb; 8(2):271-8. PMID: 9048346.
    View in: PubMed
  15. Malluche HH, Sawaya BP, Faugere MC. Dialysis: current status, contemporary limitations and future challenges. Kidney Int Suppl. 1995 Aug; 50:S37-9. PMID: 8544434.
    View in: PubMed